Crewe Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-300
Closed -$16.2K – 914
2023
Q1
$16.2K Hold
300
– – ﹤0.01% 469
2022
Q4
$17.9K Hold
300
– – ﹤0.01% 438
2022
Q3
$14K Sell
300
-77
-20% -$3.85K ﹤0.01% 561
2022
Q2
$17K Buy
+377
New +$19.3K ﹤0.01% 460

Other funds holding EHC

Crewe Advisors's EHC Position: Q2 2023 in Review

Crewe Advisors sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 300 shares — an estimated $16.2K sold.

Crewe Advisors first reported a position in EHC in Q2 2022 and held it in 4 quarters. The position peaked at $17.9K in Q4 2022. 385 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

  • Crewe Advisors reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
  • Crewe Advisors sold 300 Encompass Health shares in Q2 2023, an estimated $16.2K.
  • Crewe Advisors first reported a position in Encompass Health in Q2 2022 and held it in 4 quarters.
  • Crewe Advisors's Encompass Health position peaked at $17.9K in Q4 2022.
  • 385 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on Crewe Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.